Core Scientific Director Purchases 7,000 Shares

Eric Stanton Weiss, a Director at Core Scientific (NASDAQ:CORZ), purchased 7,000 shares of common stock on Aug. 18, 2026, according to a recent SEC Form 4 filing.

Transaction summary

Metric	Value
Transaction value	$134,330
Shares purchased	7,000
Post-transaction shares (directly held)	259,262
Post-transaction value	$4.9 million

Transaction value based on SEC Form 4 weighted average purchase price ($19.19); post-transaction value based on Aug. 18, 2026, market close ($18.85).

Key questions

• What was the execution context for this purchase?
  The shares were acquired in multiple transactions at prices ranging from $18.78 to $19.59, resulting in a weighted-average cost of $19.19 per share.
• How does this purchase affect the director's total stake?
  Weiss now directly holds 259,262 shares of common stock, representing an 0.08% ownership interest in the company.
• What are the core business operations of the company?
  Core Scientific is a North American enterprise primarily engaged in digital asset mining and providing colocation services for distributed ledger technology, operating specialized data centers to process blockchain transactions.
• How has the stock performed leading up to this transaction?
  The company's shares were priced at $18.72 as of the Aug. 19, 2026, market close, following a period where the stock delivered a 30% return over the 12 months ending on the transaction date.

Company Overview

Metric	Value
Share Price (as of market close 2026-08-19)	$18.72
Market Capitalization	$6 billion
Revenue (TTM)	$440.3 million
Net Income (TTM)	-$1.6 billion

Company Snapshot

• Core Scientific operates digital asset mining facilities and provides colocation services for distributed ledger technology infrastructure, generating revenue through proprietary cryptocurrency mining operations and hosting services for third-party blockchain network participants.
• The company generates revenue through two primary channels: direct digital asset mining conducted within its owned and operated data centers, and colocation services that leverage its specialized computing hardware and infrastructure to support external clients' blockchain operations.
• Core Scientific serves enterprise clients and digital asset participants who require high-performance computing infrastructure, targeting organizations seeking reliable, scalable hosting solutions for blockchain network operations and cryptocurrency mining.

Core Scientific operates a substantial North American infrastructure platform with 325 employees and $6 billion in market capitalization, positioning itself as a significant player in the digital asset mining and blockchain infrastructure sectors. The company's competitive advantage derives from its owned-and-operated data centers, equipped with specialized computing hardware optimized for blockchain transaction processing and digital asset mining. With TTM revenue of $440.3 million, Core Scientific has established a material revenue base while navigating the capital-intensive and volatile digital asset market through diversified revenue streams combining proprietary mining operations with third-party colocation services.

What this transaction means for investors

The Core Scientific stock price has performed well over the last year, climbing 34.4%. In comparison, the S&P 500 is up 18.1% over the same period. With a strong performance like that, it may be common to see some executives sell shares. But an insider buying into a rising stock price is a bullish signal for shareholders, as it indicates that Weiss expects shares to keep climbing. His purchase of 7,000 shares adds to his substantial holdings that now total nearly 260,000.

In addition to Weiss's purchase, another bullish signal for Core Scientific's stock price is how analysts view the company. Out of 18 who cover the stock, 94% rate it a buy, while 6% rate it a hold, according to CNN. From that group, the median one-year price target is $36, representing a gain of 92.2% from today's price ($18.73). The highest price target of $55 is even more bullish, representing a 193.6% gain. And even the lowest price target, $28, would still represent a gain of nearly 50%. With a rising stock price, insider buying, and bullish analyst outlooks, there are a lot of positive signals about where the Core Scientific stock price could head next.

Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.